Alex Marson is Director of the Gladstone-UCSF Institute of Genomic Immunology and Professor in the UCSF Department of Medicine, Division of Infectious Diseases. He serves as the Director of the Parker Institute of Cancer Immunotherapy at Gladstone, among other roles. Dr. Marson’s work aims to understand the genetic programs controlling human immune cell function in health and disease, with an emphasis on developing and applying CRISPR genome engineering tools to primary immune cells, especially T cells. Combining genomics and gene editing approaches, the lab works to assess the consequences of coding and noncoding genetic variation on immune cell function and autoimmune disease risk and to genetically engineer human immune cells to target cancer, autoimmunity, and infectious diseases.
the Gladstone-UCSF